Nourish Raises $70M Series B to Tackle Chronic Disease with AI-Powered Nutrition Care

April 23, 2025 – New York, NY – Nourish, the leading provider of nutrition counseling in the country, today announced a $70 million Series B funding round, bringing total funding to $115 million. The round was led by J.P. Morgan Private Capital’s Growth Equity Partners, with participation from Thrive Capital, Index Ventures, Y Combinator, Maverick Ventures, BoxGroup, Atomico, G Squared, and Pinegrove Opportunity Partners. The funding will accelerate product development, expand Nourish’s Registered Dietitian (RD) network, and deepen strategic partnerships across the healthcare ecosystem. Nourish will also continue to grow its team across all functions.

Nourish was founded just over three years ago by three close friends who experienced firsthand the power of food as medicine by working with an RD to address their own chronic conditions. The company connects patients, dietitians, and insurance payers through a fully-integrated virtual care platform, making it easy to access high-quality, insurance-covered dietitian care for every major nutrition-related condition. The company now serves hundreds of thousands of patients across all 50 states and employs over 3,000 W-2 RDs — the largest network in the country. Nourish partners with national commercial, Medicare, and Medicaid plans, covering hundreds of millions of lives, with 94% of patients paying $0 out of pocket.

“We built Nourish to make healthcare radically better for millions of Americans — it’s the care we wanted ourselves during our own patient journeys,” said Aidan Dewar, co-founder and CEO. “We wanted to build a patient-friendly healthcare system with lifestyle change and nutrition as a first-line treatment, not an afterthought. We're combining cutting-edge AI with the best RD team in the country to deliver personalized care that actually works, at a fraction of the cost of traditional medicine. It is not only more effective and accessible, but also more human.”

Nourish was built on a simple but urgent premise: nutrition-related chronic disease is the largest and most overlooked crisis in the world. Today, 60% of Americans live with at least one chronic condition, and 40% have two or more. Nutrition-related cardiometabolic conditions like obesity, diabetes, and heart disease together account for the vast majority of the nation's healthcare spend. Working with an RD is one of the most effective interventions available, but fewer than 1% of eligible Americans use their covered benefits due to a lack of awareness and limited access.

Nourish’s model is already delivering meaningful clinical results, with patients seeing major improvements in clinical markers like A1C and LDL. Nourish’s recently published data shows patients on GLP-1s like Ozempic lost 33% more weight when paired with a Nourish RD, while also reporting better medication adherence and reduced side effects. 

“Our healthcare system is at an inflection point, with chronic disease rates and costs rising to unsustainable levels,” said Sam Perkins, co-founder, President and COO of Nourish. “Payers are under growing pressure to find scalable solutions that actually work. Nourish meets this need by addressing the root cause of chronic disease — giving payers a powerful new lever to improve outcomes, bend the cost curve, and deliver a care experience members love.”

Nourish’s app supports patients with AI meal tracking, wearable and lab integrations, recipes, and more. Nourish also equips RDs with an AI copilot that automates note-taking, surfaces clinical insights, and eliminates administrative burden — enabling them to deliver best-in-class care​.

“Nourish is addressing one of our country’s most urgent challenges with a compelling outcomes-driven and AI-native approach,” said Paris Heymann, Co-Managing Partner of J.P. Morgan Growth Equity Partners. “I’m excited to continue supporting a category-defining company like Nourish, with a unique blend of mission, vision, and measurable impact.”